These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
276 related articles for article (PubMed ID: 23195389)
1. A psychometric validation of two brief measures to assess palliative need in patients severely affected by multiple sclerosis. Sleeman KE; Higginson IJ J Pain Symptom Manage; 2013 Sep; 46(3):406-12. PubMed ID: 23195389 [TBL] [Abstract][Full Text] [Related]
2. Individualized quality of life of severely affected multiple sclerosis patients: practicability and value in comparison with standard inventories. Giovannetti AM; Pietrolongo E; Giordano A; Cimino V; Campanella A; Morone G; Fusco A; Lugaresi A; Confalonieri P; Patti F; Grasso MG; Ponzio M; Veronese S; Solari A Qual Life Res; 2016 Nov; 25(11):2755-2763. PubMed ID: 27125955 [TBL] [Abstract][Full Text] [Related]
3. Screening for depression in advanced disease: psychometric properties, sensitivity, and specificity of two items of the Palliative Care Outcome Scale (POS). Antunes B; Murtagh F; Bausewein C; Harding R; Higginson IJ; J Pain Symptom Manage; 2015 Feb; 49(2):277-88. PubMed ID: 25131889 [TBL] [Abstract][Full Text] [Related]
4. Psychometric Properties of a Generic, Patient-Centred Palliative Care Outcome Measure of Symptom Burden for People with Progressive Long Term Neurological Conditions. Gao W; Crosby V; Wilcock A; Burman R; Silber E; Hepgul N; Chaudhuri KR; Higginson IJ; PLoS One; 2016; 11(10):e0165379. PubMed ID: 27780237 [TBL] [Abstract][Full Text] [Related]
5. Use of the palliative outcome scale in Argentina: a cross-cultural adaptation and validation study. Eisenchlas JH; Harding R; Daud ML; Pérez M; De Simone GG; Higginson IJ J Pain Symptom Manage; 2008 Feb; 35(2):188-202. PubMed ID: 18082359 [TBL] [Abstract][Full Text] [Related]
6. The reliability and validity of pain interference measures in persons with multiple sclerosis. Osborne TL; Raichle KA; Jensen MP; Ehde DM; Kraft G J Pain Symptom Manage; 2006 Sep; 32(3):217-29. PubMed ID: 16939846 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of a new model of short-term palliative care for people severely affected with multiple sclerosis: a randomised fast-track trial to test timing of referral and how long the effect is maintained. Higginson IJ; Costantini M; Silber E; Burman R; Edmonds P Postgrad Med J; 2011 Nov; 87(1033):769-75. PubMed ID: 21978993 [TBL] [Abstract][Full Text] [Related]
8. Tried and tested: the psychometric properties of the multiple sclerosis impact scale (MSIS-29) in a population-based study. Gray O; McDonnell G; Hawkins S Mult Scler; 2009 Jan; 15(1):75-80. PubMed ID: 18829636 [TBL] [Abstract][Full Text] [Related]
9. The Cannabinoid Use in Progressive Inflammatory brain Disease (CUPID) trial: a randomised double-blind placebo-controlled parallel-group multicentre trial and economic evaluation of cannabinoids to slow progression in multiple sclerosis. Ball S; Vickery J; Hobart J; Wright D; Green C; Shearer J; Nunn A; Cano MG; MacManus D; Miller D; Mallik S; Zajicek J Health Technol Assess; 2015 Feb; 19(12):vii-viii, xxv-xxxi, 1-187. PubMed ID: 25676540 [TBL] [Abstract][Full Text] [Related]
10. Development and validation of a core outcome measure for palliative care: the palliative care outcome scale. Palliative Care Core Audit Project Advisory Group. Hearn J; Higginson IJ Qual Health Care; 1999 Dec; 8(4):219-27. PubMed ID: 10847883 [TBL] [Abstract][Full Text] [Related]
11. Validity, Reliability, and Responsiveness of the Thai Palliative Care Outcome Scale Staff and Patient Versions Among Cancer Patients. Pukrittayakamee P; Sapinum L; Suwan P; Harding R J Pain Symptom Manage; 2018 Sep; 56(3):414-420. PubMed ID: 29885457 [TBL] [Abstract][Full Text] [Related]
12. Improving the evaluation of therapeutic interventions in multiple sclerosis: development of a patient-based measure of outcome. Hobart JC; Riazi A; Lamping DL; Fitzpatrick R; Thompson AJ Health Technol Assess; 2004 Mar; 8(9):iii, 1-48. PubMed ID: 14982653 [TBL] [Abstract][Full Text] [Related]
13. Validation of the SymptoMScreen with performance-based or clinician-assessed outcomes. Fitzgerald KC; Salter A; Tyry T; Fox RJ; Cutter G; Mowry EM; Marrie RA Mult Scler Relat Disord; 2019 Apr; 29():86-93. PubMed ID: 30690340 [TBL] [Abstract][Full Text] [Related]
14. Comparison of patient-reported outcome measures in multiple sclerosis. Schäffler N; Schönberg P; Stephan J; Stellmann JP; Gold SM; Heesen C Acta Neurol Scand; 2013 Aug; 128(2):114-21. PubMed ID: 23398571 [TBL] [Abstract][Full Text] [Related]
15. Preliminary validation study of the Spanish version of the satisfaction with life scale in persons with multiple sclerosis. Lucas-Carrasco R; Sastre-Garriga J; Galán I; Den Oudsten BL; Power MJ Disabil Rehabil; 2014; 36(12):1001-5. PubMed ID: 23962197 [TBL] [Abstract][Full Text] [Related]
16. Validation of the World Health Organization Disability Assessment Schedule II (WHODAS-II) in patients with multiple sclerosis. Magistrale G; Pisani V; Argento O; Incerti CC; Bozzali M; Cadavid D; Caltagirone C; Medori R; DeLuca J; Nocentini U Mult Scler; 2015 Apr; 21(4):448-56. PubMed ID: 25092769 [TBL] [Abstract][Full Text] [Related]
17. Apathy in multiple sclerosis: a validation study of the apathy evaluation scale. Raimo S; Trojano L; Spitaleri D; Petretta V; Grossi D; Santangelo G J Neurol Sci; 2014 Dec; 347(1-2):295-300. PubMed ID: 25455303 [TBL] [Abstract][Full Text] [Related]
18. Self-rating makes the difference: identifying palliative care needs of patients feeling severely affected by multiple sclerosis. Strupp J; Golla H; Galushko M; Buecken R; Ernstmann N; Hahn M; Pfaff H; Voltz R Palliat Support Care; 2015 Jun; 13(3):733-40. PubMed ID: 24849300 [TBL] [Abstract][Full Text] [Related]
19. Validation of a core outcome measure for palliative care in Africa: the APCA African Palliative Outcome Scale. Harding R; Selman L; Agupio G; Dinat N; Downing J; Gwyther L; Mashao T; Mmoledi K; Moll T; Sebuyira LM; Panjatovic B; Higginson IJ Health Qual Life Outcomes; 2010 Jan; 8():10. PubMed ID: 20100332 [TBL] [Abstract][Full Text] [Related]
20. Evidence-based measurement in multiple sclerosis: the psychometric properties of the physical and psychological dimensions of three quality of life rating scales. Riazi A; Hobart JC; Lamping DL; Fitzpatrick R; Thompson AJ Mult Scler; 2003 Aug; 9(4):411-9. PubMed ID: 12926848 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]